Literature DB >> 25367270

Quantitative Analysis of HSV Gene Expression during Lytic Infection.

Anne-Marie W Turner1, Jesse H Arbuckle, Thomas M Kristie.   

Abstract

Herpes Simplex Virus (HSV) is a human pathogen that establishes latency and undergoes periodic reactivation, resulting in chronic recurrent lytic infection. HSV lytic infection is characterized by an organized cascade of three gene classes; however, successful transcription and expression of the first, the immediate early class, is critical to the overall success of viral infection. This initial event of lytic infection is also highly dependent on host cell factors. This unit uses RNA interference and small molecule inhibitors to examine the role of host and viral proteins in HSV lytic infection. Methods detailing isolation of viral and host RNA and genomic DNA followed by quantitative real-time PCR allow characterization of impacts on viral transcription and replication, respectively. Western blots can be used to confirm quantitative PCR results. This combination of protocols represents a starting point for researchers interested in virus-host interactions during HSV lytic infection.
Copyright © 2014 John Wiley & Sons, Inc.

Entities:  

Keywords:  Herpes Simplex Virus; RNAi; lytic infection; qPCR; small molecule inhibitors; western blot

Mesh:

Substances:

Year:  2014        PMID: 25367270      PMCID: PMC4238182          DOI: 10.1002/9780471729259.mc14e05s35

Source DB:  PubMed          Journal:  Curr Protoc Microbiol


  18 in total

1.  A PCR primer bank for quantitative gene expression analysis.

Authors:  Xiaowei Wang; Brian Seed
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

2.  Resources for international biosafety guidelines and regulations.

Authors: 
Journal:  Curr Protoc Microbiol       Date:  2005-07

3.  Phosphorylation of the VP16 transcriptional activator protein during herpes simplex virus infection and mutational analysis of putative phosphorylation sites.

Authors:  Søren Ottosen; Francisco J Herrera; James R Doroghazi; Angela Hull; Sheenu Mittal; William S Lane; Steven J Triezenberg
Journal:  Virology       Date:  2005-11-17       Impact factor: 3.616

4.  Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1.

Authors:  Jing Huang; Jennifer R Kent; Brandon Placek; Kelly A Whelan; Charles M Hollow; Ping-Yao Zeng; Nigel W Fraser; Shelley L Berger
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Analysis of herpes simplex virus nucleoprotein complexes extracted from infected cells.

Authors:  P F Pignatti; E Cassai
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

6.  The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection.

Authors:  Aarthi Narayanan; William T Ruyechan; Thomas M Kristie
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

7.  Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection.

Authors:  Anna R Cliffe; David M Knipe
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

8.  Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency.

Authors:  Yu Liang; Jodi L Vogel; Aarthi Narayanan; Hua Peng; Thomas M Kristie
Journal:  Nat Med       Date:  2009-10-25       Impact factor: 53.440

9.  A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance.

Authors:  Athanasia Spandidos; Xiaowei Wang; Huajun Wang; Stefan Dragnev; Tara Thurber; Brian Seed
Journal:  BMC Genomics       Date:  2008-12-24       Impact factor: 3.969

10.  A targeted RNA interference screen reveals novel epigenetic factors that regulate herpesviral gene expression.

Authors:  Hyung Suk Oh; Kevin F Bryant; Thomas J F Nieland; Aprotim Mazumder; Mukta Bagul; Mark Bathe; David E Root; David M Knipe
Journal:  MBio       Date:  2014-02-04       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.